Peter Henry

Peter Henry serves as Associate Professor in the Department of Pharmacology and Toxicology within the School of Biomedical Sciences at The University of Western Australia. His research focuses on receptor-effector systems within the lungs of healthy and diseased individuals, with significant contributions to understanding airway physiology and pharmacology. He leads the Respiratory Pharmacology Research group and coordinates the Major in Pharmacology within the Bachelor of Biomedical Sciences program.

Dr. Henry's educational background includes a BSc and PhD from Western Australia. His research has been published in prestigious journals including Nature and high-impact specialty journals such as American Journal of Respiratory and Critical Care Medicine. He has published nearly 100 papers, with approximately 75% appearing in journals with an impact factor of 3 or higher, and serves as first or senior author on 65% of his publications.

His research interests center on receptor function and distribution in allergic and viral airway disease, with specific expertise in endothelin, airway receptors, cholinergic receptor stimulating agents, asthma, smooth muscle, and proteinase activated receptor 2. His work bridges fundamental pharmacological mechanisms with clinical applications in respiratory diseases.

Analysis of his recent publications reveals a strong focus on airway physiology, with particular attention to mucin secretion pathways, airway remodeling, and the development of novel experimental systems for studying airway function. His research spans both basic science investigations and translational applications with potential clinical relevance for asthma and other obstructive lung diseases.

Scientific Awards and Recognition:

• UWA Student Guild's Student Choice Awards for demonstrating strong commitment to excellence, learning and student engagement
• Vice Chancellor recognition in 2017 for units PHAR3320 and PHAR3321 as 'Consistently Excellent'
• Numerous nominations for Faculty 'Excellence in Teaching' award
• Nominations for 'Excellence in Supervision' awards

Dr. Henry has successfully attracted substantial research funding, including $4.8 million from the NH&MRC (with $2.3 million as Chief Investigator), and has maintained ongoing research funding. He has supervised numerous Honours and PhD students who have achieved excellent results. His service contributions include membership on the Asthma Foundation of Western Australia Medical Research Advisory Committee for over 10 years, editorial roles for Pulmonary Pharmacology & Therapeutics and Frontiers in Pharmacology, and extensive committee service within the university.

He leads the Respiratory Pharmacology Research group and has developed strong collaborative links with academic and industry research groups both within Australia and internationally.